| Financial Year |
March 31 2023 |
| Monetary Funds |
130,822,204.52 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
2,810,354.16 |
| Advances to Suppliers |
13,458,469.07 |
| Other Receivables |
19,320,797.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
781,031,825.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
35,937,181.41 |
| Total Current Assets |
983,633,832.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,591,052.87 |
| Investment Properties |
51,979,793.23 |
| Fixed Assetes |
434,614,313.91 |
| Under-construction Projects |
21,559,894.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
258,893,241.53 |
| R&D expenses |
-- |
| Goodwill |
22,509,354.10 |
| Long-Term Deferred and Prepaid Expenses |
8,600,739.04 |
| Deferred Income Tax Assets |
29,109,108.97 |
| Other Non-Current Assets |
7,148,000.00 |
| Sub-Total of Non-Current Assets |
982,124,106.44 |
| Total Assets |
1,965,757,938.53 |
| Short-Term Loans |
150,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
643,159,031.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,782,385.81 |
| Taxes Payable |
19,063,655.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,136,147.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
32,053,748.62 |
| Other Current Liabilities |
1,484,459.62 |
| Sub-Total of Current Liabilities |
921,316,925.86 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,057,503.00 |
| Deferred Income Tax Liabilities |
7,886,426.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
99,325,004.73 |
| Total Liabilities |
1,020,641,930.59 |
| Paid-In Capital(Or Share Stock) |
480,793,320.00 |
| Capital Surplus |
187,212,877.40 |
| Surplus Reserve |
117,411,424.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
149,418,035.73 |
| Minority Stockholder's Interest |
3,329,477.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
941,786,530.43 |
| Owner's Equity（Stockholder's Equity） |
945,116,007.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,965,757,938.53 |
